Ikaros as a downstream mediator of BCR blockade therapy in B-cell non-Hodgkin lymphoma

Oncoscience. 2022 Nov 28:9:64-65. doi: 10.18632/oncoscience.568. eCollection 2022.
No abstract available

Keywords: B-NHL; Bruton’s tyrosine kinase; Ikaros; combination therapies; phosphoproteomics.

Publication types

  • Editorial